Back to Treatments

Treatment

Regorafenib

1
Conditions
10
Trials
7,000
Participants
30%
Average Safety

Condition Evidence

Colon and rectum cancer

10 trials · 7,000 participants

50% effectiveness · 30% safety
Regorafenib | DFDA